Ellis Liang

415-875-2431
eliang@fenwick.com
Associate
Intellectual Property

Ellis
Liang

Ellis
Liang

Ellis
Liang

Associate
Intellectual Property

Ellis advises technology companies and investors in complex transactions involving intellectual property, including mergers and acquisitions, financings and licensing agreements. She counsels a variety of clients from start-ups to Fortune 500 companies in diverse industries, including software, digital media, artificial intelligence, cryptocurrency, Web3 and fintech.

Prior to joining Fenwick, Ellis was a corporate associate at a leading law firm in New York City, where she focused on public company mergers and acquisitions and hostile takeover defense.

Ellis received her J.D. from Yale Law School, her M.B.A. from Yale School of Management, and her B.A. in Economics from Princeton University. She advocated for journalists as part of the Media Freedom and Information Access Clinic at Yale and represented artists and entrepreneurs through the Berkman Klein Center for Internet & Society at Harvard. Prior to law school, Ellis was an editorial writer for The Wall Street Journal and a reporter for South China Morning Post in Hong Kong.

Ellis is a recipient of the Don H. Liu Scholarship for future Asian American leaders within the legal profession. She was also a research assistant for Justice Goodwin Liu on “A Portrait of Asian Americans in the Law,” a study on the career paths and challenges of Asian American lawyers.

  • Databricks in its $1.3 billion acquisition of MosaicML
  • Meta in its acquisition of Camouflaj and Lofelt
  • Databricks in its acquisition of Okera, bit.io and Rubicon
  • NS1 in its acquisition by IBM
  • Armorblox in its acquisition by Cisco
  • LeapYear Technologies in its acquisition by Snowflake
  • TD Ameritrade’s Strategic Development Committee in its $26 billion all-stock merger with Charles Schwab
  • Thermo Fisher Scientific in its $12.5 billion all-cash tender offer for QIAGEN
  • Thermo Fisher Scientific in its $550 million cash acquisition of Mesa Biotech
  • VEREIT in its all-stock acquisition by Realty Income, creating a $50 billion combined company, and its spin-off of office property assets
  • Bluerock Residential in its $3.6 billion acquisition by Blackstone and its spin-off of its single-family rental business
  • Kansas City Southern in its now terminated $33.6 billion acquisition by Canadian National Railway

* Includes experience from a previous firm

  • Databricks in its $1.3 billion acquisition of MosaicML
  • Meta in its acquisition of Camouflaj and Lofelt
  • Databricks in its acquisition of Okera, bit.io and Rubicon
  • NS1 in its acquisition by IBM
  • Armorblox in its acquisition by Cisco
  • LeapYear Technologies in its acquisition by Snowflake
  • TD Ameritrade’s Strategic Development Committee in its $26 billion all-stock merger with Charles Schwab
  • Thermo Fisher Scientific in its $12.5 billion all-cash tender offer for QIAGEN
  • Thermo Fisher Scientific in its $550 million cash acquisition of Mesa Biotech
  • VEREIT in its all-stock acquisition by Realty Income, creating a $50 billion combined company, and its spin-off of office property assets
  • Bluerock Residential in its $3.6 billion acquisition by Blackstone and its spin-off of its single-family rental business
  • Kansas City Southern in its now terminated $33.6 billion acquisition by Canadian National Railway

* Includes experience from a previous firm